News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17892)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Genetown
Verastem Announces Public Offering of Common Stock
Verastem announced that it intends to offer and sell $25 million of its common stock in an underwritten public offering.
December 14, 2017
·
3 min read
Pharm Country
Tauriga Sciences Fully Repays $80,000 USD 5% Face Value Convertible Debenture Issued to GS Capital Partners, LLC on June 27, 2017 for One Time Cash Payment of $108,164.38 USD
This convertible debenture, which was issued by the Company on June 27, 2017, has been fully repaid for a one-time cash payment of $108,164.38 USD. Accordingly, this debt has been removed from the Company’s balance sheet.
December 14, 2017
·
3 min read
Policy
Shire’s New Formulation of ONCASPAR (pegaspargase) Receives Marketing Authorization in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)
Shire today announced that the European Commission granted Marketing Authorization for lyophilized ONCASPAR, as a component of antineoplastic combination therapy in acute lymphoblastic leukemia in pediatric patients from birth to 18 years, and in adult patients.
December 14, 2017
·
4 min read
Business
Cerveau Technologies Ink R&D Deal With KU Leuven University, Belgium
The deal will support multiple projects over the next several years.
December 14, 2017
·
2 min read
Biotech Beach
Puma Biotechnology Added to NASDAQ Biotechnology Index
Puma will be added to the NBI effective prior to market open on Monday, December 18, 2017.
December 14, 2017
·
3 min read
Business
NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform
The NuVasive CPD team will support the Company’s surgeon partners for the lifetime of their careers.
December 14, 2017
·
6 min read
Business
PURE Bioscience Reports Fiscal 2018 Q1 Financial Results
Revenues for the fiscal first quarter ended October 31, 2017 decreased 13% to $464,000 compared with prior first quarter revenues of $531,000.
December 14, 2017
·
9 min read
Pharm Country
AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse
The AmerisourceBergen Foundation today announced the launch of a municipal support program that aims to promote the safe disposal of opioids by providing communities nationwide with resources to deactivate expired or unused prescription medications.
December 14, 2017
·
3 min read
ICC International Cannabis Corporation Changes its Name to ICC Labs Inc. to Reflect Medicinal and Pharmaceutical Opportunity
The Company is expected to commence trading under its new name at the opening of trading on the day after it receives final approval from the TSX Venture Exchange.
December 14, 2017
·
5 min read
FDA
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis
The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program.
December 14, 2017
·
18 min read
Previous
14 of 15
Next